Coral Laboratories Ltd (CORALAB)

BSE · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

₹484.35

As of 30 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close ₹484.35 on 30 Oct 2026. The share price traded between ₹360.00 and ₹679.00 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close ₹484.35

Low ₹360.00High ₹679.00

Market cap₹194 crorelast close × shares
P/E9.0on reported profit, last four quarters
Profit, last 12 months₹21.46 crto shareholders
Profit incl. minorities₹19.00 crlast 12 months
Return on equity7.8%year to Mar 2026
EBITDA margin18.0%year to Mar 2026
Debt to equity0.02year to Mar 2026
Net margin18.6%year to Mar 2026
Dividend yieldnonelast 12 months

Price trend

Revenue and profit

RevenueNet profit₹ crore
050100150
YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue76788411586
Net profit96162416
EBITDA margin11.0%4.9%19.0%23.0%18.0%
Borrowings60044

₹ crore. Over three years, compounded: revenue grew 3.3% a year, net profit grew 38.7% a year.

Recent filings

Questions about Coral Laboratories Ltd

What is Coral Laboratories Ltd's market value?

Coral Laboratories Ltd's market value is ₹194 crore as of 30 Oct 2026 close: the last close times the shares in issue. Its P/E is 9.0, the last close over earnings per share for the last four reported quarters.

Go further with CORALAB

Free to start: test a trading idea on CORALAB's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceuticals), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

P/E 9.0 is the close over earnings per share, the profit that belongs to the company's shareholders (market cap divided by P/E: 21 crore for the last 12 months, shown above). The net profit including the share owned by minority shareholders of subsidiaries is 19 crore; market cap divided by that gives 10.2. The last 12 months are the four latest reported quarters, so their profit can differ from the newest year's in the table below.